Revascularisation for Symptomatic Peripheral Artery Disease: External Applicability of the VOYAGER PAD Trial

Mette Søgaard*, Peter B. Nielsen, Flemming Skjøth, Torben B. Larsen, Nikolaj Eldrup

*Corresponding author for this work

Research output: Contribution to journalJournal articleResearchpeer-review

1 Citation (Scopus)
2 Downloads (Pure)
Original languageEnglish
JournalEuropean Journal of Vascular and Endovascular Surgery
Volume63
Issue number2
Pages (from-to)285-294
Number of pages10
ISSN1078-5884
DOIs
Publication statusPublished - Feb 2022

Bibliographical note

Copyright © 2021 The Author(s). Published by Elsevier B.V. All rights reserved.

Keywords

  • Aspirin
  • External applicability
  • Generalisability
  • Peripheral arterial disease
  • Rivaroxaban
  • VOYAGER PAD trial

Fingerprint

Dive into the research topics of 'Revascularisation for Symptomatic Peripheral Artery Disease: External Applicability of the VOYAGER PAD Trial'. Together they form a unique fingerprint.

Cite this